Prevalence of Small Intestinal Bacterial Overgrowth (SIBO) in Women With Endometriosis

NCT07922408 · ctgov not_yet_recruiting
Enrollment
50
Start
2027-02-01
Completion
2030-12-01
Last updated
2026-11-06
Has results
False
Countries
Switzerland

Conditions

SIBOEndometriosis

Tagged with

endometriosis

Interventions

Eligibility criteria
Inclusion Criteria: * Informed Consent as documented by signature * Age 18 or older * Premenopausal status (menopause is defined as amenorrhea lasting one year or longer) * Diagnosis of endometriosis (Ziwig Endotest® or histologically confirmed) Exclusion Criteria: * Pregnant (positive β-HCG in the blood) or breastfeeding women Inability to follow the procedures of the study (due to language problems, psychological disorders, dementia) * Presence of medical conditions contraindicating a saliva test * Diagnosis of another gastrointestinal major diagnosis * Presence of any condition known to associate with/ increase risk for SIBO (other than endometriosis) namely 1. Scleroderma, diabetic neuropathy, amyloidosis, post-vagotomy, morbid obesity , non-alcoholic fatty liver disease, liver cirrhosis, cystic fibrosis, irritable bowel syndrome, altered intestinal anatomy such as diverticula. 2. Patients with intake of medicaments known to inhibit motility or gastric acid secretion 3. Patients with choledocholithiasis or malignancy within the biliary tree or at the ampullary region obstructing biliary outflow
License: public-domain-us · commercial use OK · attribution required
Courtesy of ClinicalTrials.gov / U.S. National Library of Medicine

No linked papers in the corpus yet.